[Experimental approach to the pathogenesis of systemic lupus erythematosus].
D000818:Animals; D000936:Antigen-Antibody Complex; D001323:Autoantibodies / Q000032:analysis; D003520:Cyclophosphamide / Q000627:therapeutic use; D004247:DNA / Q000032:analysis; D004195:Disease Models, Animal; D005260:Female; D005921:Glomerulonephritis / Q000209:etiology / Q000276:immunology*; D006493:Heparin / Q000627:therapeutic use; D006824:Hybridization, Genetic; D007105:Immune Complex Diseases; D007154:Immune System Diseases; D009052:Leukemia Virus, Murine; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology / Q000276:immunology*; D051379:Mice; D008814:Mice, Inbred NZB; D011233:Precipitin Tests; D011342:Procainamide / Q000009:adverse effects
D000936:Antigen-Antibody Complex; D001323:Autoantibodies; D003520:Cyclophosphamide; D006493:Heparin; D004247:DNA; D011342:Procainamide
Approche expérimentale de la pathogénie du lupus érythémateux.